Featured
August 14, 2026
In a commentary published in Bio-IT World, ASAP Managing Director Sonya Dumanis shares how Parkinson's disease diagnosis and treatment is shifting away from broad symptom management towards a precision medicine approach grounded in molecular profiling, novel biomarkers, and global data-sharing.
In this blog, Hetal Shah, PhD, senior program officer, and Dana Lewis, PhD, program officer at ASAP and the Coalition for Aligning Science, discuss highlights from the 2026 CRN Annual Investigators Meeting, emphasizing how new research themes and cross-disciplinary collaboration are accelerating progress in Parkinson’s disease research.
Read More
In this blog, ASAP shares an overview of the Collaborative Research Network (CRN) 2025–2026 Impact Report, highlighting key discoveries, cross-cutting scientific themes, field-enabling resources, and infrastructure efforts accelerating breakthroughs in Parkinson's disease research.
Read More
SPARC dives into how Aligning Science Across Parkinson's (ASAP) and The Michael J. Fox Foundation (MJFF) are advancing Parkinson's research through open-access and open-science policies that mandate the early, public sharing of publications, data, protocols, and lab resources.
View Story
In a commentary published in Bio-IT World, ASAP Managing Director Sonya Dumanis shares how Parkinson's disease diagnosis and treatment is shifting away from broad symptom management towards a precision medicine approach grounded in molecular profiling, novel biomarkers, and global data-sharing.
View Story
In this Q2 2026 edition of the ASAP Research Round-Up, we highlight how our programs produced resources for the scientific community, supported venues that facilitate collaboration, and provided new opportunities for researchers to accelerate discoveries in Parkinson’s research.
Read More
As an extension of the ASAP CRN Impact Report 2020–2024, this report highlights the cross-cutting scientific themes, field-enabling resources, infrastructure efforts, and key discoveries accelerating breakthroughs in PD research across our Collaborative Research Network (CRN).
View Story
In July 2026, GP2 announced the 12th data release on the Terra and the Verily® Workbench platforms in collaboration with AMP® PDRD. This release includes 21,156 additional genotyped participants and 25,046 additional whole genome sequencing (WGS) participants.
View Story
In this blog, ASAP shares highlights from the 2025 Cell Biology of Parkinson’s Disease Conference that brought together investigators and trainees to discuss the intricacies of Parkinson’s disease at the cellular level.
Read More
In this blog, ASAP discusses the expansion of the CRN Cloud platform, which has grown to house over 50 harmonized multi-omics datasets while integrating new interoperability features and analysis tools to streamline collaboration across the Parkinson’s research community.
Read More
